Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
Breye Therapeutics, a biopharmaceutical firm that provide cutting-edge oral treatments for the management of retinal vascular diseases.
EnergyRe is at the center of the clean energy future.
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
MATR Foods is a food-tech startup that provides fungi-based food ingredients.
Cleveland Diagnostics is a diagnostics company developing efficacious, affordable diagnostics tests to improve cancer diagnostics.
Unlocking human potential with breakthrough mammary biotechnology.
LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.
Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.
Reduced develops natural flavor enhancers from upcycled produce.
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Bactolife is a biotechnology company that develops biological solutions to support gut health.
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
The Protein Brewery specializes in developing and making animal-free-based protein in a sustainable way.
Sidera Bio harness human genetics, that helps in transformative medicines for patients.
Chromologics develops innovative natural food colorants.
Booster Therapeutics is a biotech company that offers regulation of cellular homeostasis, as well as develops medicines for aging diseases.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.
Novo Holdings has invested in 216 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novo Holdings's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 25 different industry categories.
Among tracked funding rounds, Praxis Precision Medicines received $575.0M in a Post Ipo Equity round. Novo Holdings's total known invested capital is $15.2B.
Novo Holdings's average investment size is $84.4M across its portfolio of 216 companies.
Recent Novo Holdings portfolio additions include Cogent Biosciences, Breye Therapeutics, EnergyRe, Harmony Biosciences, Kivu Bioscience. These companies were founded in 2020 or later.